Anebulo Pharmaceuticals Inc. Financials
ANEB
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | JUN 2025 ~1.3:1 split | JUN 2024 | JUN 2023 | JUN 2022 ~1.7:1 split | JUN 2021 |
|---|---|---|---|---|---|
| General & Administrative | $5 | $5 | $6 | $4 | $1 |
| Research & Development | $4 | $4 | $6 | $3 | $2 |
| Total Operating Expenses | $9 | $8 | $12 | $7 | $4 |
| Operating Income | -$9 | -$8 | -$12 | -$7 | -$4 |
| Non-Operating | |||||
| Net Interest Expense | -$0 | -$0 | – | – | -$0 |
| Other Non-Operating Income (Expense) | $1 | $0 | $0 | $0 | $0 |
| EBT (Earnings Before Tax) | – | – | – | – | -$4 |
| Net Income | |||||
| Net Income | -$8 | -$8 | -$12 | -$7 | -$30 |
| EPS (Basic) | -$0.25 | -$0.32 | -$0.47 | $0.29 | -$2.83 |
| EPS (Diluted) | -$0.25 | -$0.32 | -$0.47 | $0.29 | -$2.22 |
| Weighted Avg Shares (Basic) | 33.8M | 25.8M | 25.1M | 23.3M | 13.6M |
| Weighted Avg Shares (Diluted) | 33.8M | 25.8M | 25.1M | 23.3M | 13.6M |
| Shares Outstanding | 33.8M | 25.8M | 25.1M | 23.3M | 13.6M |
Anebulo Pharmaceuticals (ANEB) financials: revenue, profit and margins
Anebulo Pharmaceuticals (ANEB) generated about n/a in revenue and -$8 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
Is Anebulo Pharmaceuticals profitable?+
Anebulo Pharmaceuticals reported about -$8 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 6 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 26 Sept 2026. How this is calculated.
Fiscal year ends Jun.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ANEB
Spot a number that looks wrong? Check it in ANEB's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ANEB
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.